Neuroimaging

Neuroimaging is an essential part of diagnosis and to study in the area of Neurology and Neuroscience. It is an addition to a clinical and cognitive evaluation in the assessments of cognitive, behavioral and neurological disorders. Neuroimaging or brain imaging is to image the structure, function, and pharmacology of the nervous system mainly the brain and spinal cord.

Neuroradiologists are the one who specializes in neuroimaging techniques. Neuroimaging or brain imaging is a new discipline in medicine, neuroscience, and psychology to study the changes during various neurological and psychological conditions.

Neuroimaging can be classified into two major parts:                           

1. Structural Imaging: It deals with the structure of the nervous system and to diagnose intracranial disease and injury

2. Functional Imaging: It is used for research purposes: neurological and psychology and building brain-computer interface through cognitive neuroscience. It is also used to diagnose metabolic disease on a finer scale. 

Sub-tracks:

• Neuroimaging techniques and their relation with Neurology
• Recent advancements in Neuroimaging
• Functional magnetic resonance imaging
• Functional Magnetic Resonance Imaging (fMRI)
• Magnetoencephalography
• Cranial ultrasound
• Magnetic resonance imaging
• Positron emission tomography
• Diffuse optical imaging
• Computed axial tomography
• Single-photon emission computed tomography
• Positron Emission Tomography (PET)
• Event-related optical signal
• Magnetoencephalography (MEG) & Electroencephalography (EEG)
• Computed Tomography (CT) Scan

Market Analysis: From 2021 to 2027, the global medical imaging market is predicted to increase at a CAGR of 3.99 percent, from USD 26.52 billion in sales in 2020 to USD 35.78 billion in 2027. Due to many driving factors, the worldwide medical imaging market is predicted to rise at a significant rate. The global medical imaging market is divided into X-Ray Systems, Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Others, based on imaging technique. The market is divided into hospitals, ambulatory centres, radiology centres, and others based on the end user. The global diagnostic imaging market is expected to grow at a CAGR of 5.7 percent from 2021 to 2026, from USD 26.6 billion in 2021 to USD 35.0 billion in 2026. The increasing demand for early disease diagnosis and the broadening scope of clinical applications, the rapidly growing geriatric population and the resulting increase in the prevalence of associated diseases, technological advancements in the diagnostic imaging industry, and increasing investments, funds, and grants by public-private organizations are all driving this market forward. In 2020, the global medical imaging market was worth USD 15.9 billion, and it is predicted to increase at a compound yearly growth rate of 5.2 percent until 2028.